Court upholds decisions in Boston Scientific, Johnson & Johnson patent case

By Lisa Kerner

Erie, Pa., May 11 - The U.S. District Court in Delaware upheld two jury decisions in the patent case of Boston Scientific Corp. and Johnson & Johnson.

One jury found that Boston's Express and Taxus Express products infringed one Johnson & Johnson stent patent. It also found that the Liberte product infringed the same patent (which expired in November 2005) and an additional Johnson & Johnson stent patent.

Another jury had found that Johnson & Johnson's BX Velocity and Cypher products infringed a Boston stent patent.

In addition, the court upheld its earlier decision dismissing the Taxus Liberte product from the case, without prejudice.

No rulings have been made in the post-trial motions regarding Boston's drug coating patent.

Located in Natick, Mass., Boston Scientific develops, manufactures and markets medical devices.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.